CSS
DERM icon

Cubist Systematic Strategies’s Journey Medical DERM Stock Holding History

Cubist Systematic Strategies’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,438
Closed -$135K – 3840
2023
Q4 		$135K Buy
+23,438
New +$104K ﹤0.01% 3113

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Cubist Systematic Strategies's DERM Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Journey Medical (DERM) in Q1 2024, closing a stake of 23,438 shares — an estimated $135K sold.

Cubist Systematic Strategies first reported a position in DERM in Q4 2023 and held it in 1 quarter. The position peaked at $135K in Q4 2023. 33 funds tracked by Wall St. Rank hold DERM as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Journey Medical position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 23,438 Journey Medical shares in Q1 2024, an estimated $135K.
  • Cubist Systematic Strategies first reported a position in Journey Medical in Q4 2023 and held it in 1 quarter.
  • Cubist Systematic Strategies's Journey Medical position peaked at $135K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Journey Medical as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.